期刊文献+

儿童重症支原体肺炎临床特征及危险因素分析 被引量:2

Clinical features and risk factors of severe cases of children mycoplasma pneumonia
下载PDF
导出
摘要 目的:探讨重症支原体肺炎( SMPP)患儿的临床特征和危险因素,为防治SMPP提供依据。方法回顾性收集52例SMPP病例和104例轻症MPP病例,比较重症组和轻症组的临床特征,分析影响SMPP发病的危险因素。结果重症组与轻症组相比,具有热程长、病程长、外周血WBC高、CRP高、ESR高、MP-IgM阳性率高、下叶病变部位比例高、大片状病变类型多见、大环内脂使用时间长等特点;影响SMPP发病的危险因素包括CRP(OR=6.228)、ESR(OR=3畅877)、MP-IgM阳性(OR=8.224)、下叶病变部位(OR=6.987)及大片状病变类型(OR=11.462)。结论初步掌握了SMPP的主要临床特征及其相关危险因素,为临床早发现、早诊断、早治疗SMPP提供依据。 Objective To explore clinical features and risk factors of severe cases of mycoplasma pneumoniae pneumoni-a ( SMPP) , provide basis for preventing and treating SMPP.Methods Retrospectively collected 52 cases of SMPP and 104 ca-ses of MPP, then compared clinical features between mild case group and severe case group, and analyzed the risk factors of inci-dence of SMPP.Results The severe case group contrast with the mild case group, existedlonger fever lasting time, longer course of disease, more WBC, higher CRP and ESR, higher positive rate of MP-IgM, much higher ratios of hypophyll diseased region, more large patches of the type of lesion and longer use time of large ring lactone.The risk factors of SMPP included in CRP (OR=6.228), ESR (OR=3.877), MP-IgM positivity (OR=8.244), hypophyll diseased region (OR=6.987) and large patches of the type of lesion (OR=11.462).Conclusion We learned the clinical features and the risk factors of severe HFMD.These might provide clinical basis for early detection, early diagnosis and early treatment of severe HFMD.
出处 《中国医院统计》 2015年第2期85-86,90,共3页 Chinese Journal of Hospital Statistics
关键词 重症肺炎 支原体肺炎 儿童 临床特征 危险因素 Severe pneumonia Mycoplasma pneumonia Childre Clinical feature Risk factors
  • 相关文献

参考文献7

二级参考文献41

  • 1雷晔飞,谭金亮,陈曼平.肺炎支原体肺炎T细胞亚群免疫球蛋白水平变化的研究[J].中国当代儿科杂志,2005,7(4):329-330. 被引量:18
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3050
  • 3陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:605
  • 4Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen[J]. Clin Microbiol Rev, 2004, 17 (4) : 697 -728.
  • 5Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children [ J ]. Pediatr Pulmonol, 2006, 41 ( 3 ) : 263-268.
  • 6Wang RS, Wang SY, Hsieh KS, Chiou YH, Huang IF, Cheng MF, et al. Necrotizing pneumonitis caused by Mycoplasma pneumoniae in pediatric patients : report of five cases and review of literature[ J ]. Pediatr Infect Dis J, 2004, 23 (6) :564-567.
  • 7Oermann C, Sockrider MM, Langston C. Severe necrotizing pneumonitis in children with Mycoplasma pneumoniae infection [ J]. Pediatr Pulmonol, 1997, 24 ( 1 ) : 61-65.
  • 8Yang J, Hooper WC, Phillips DJ, Talkington DF. Cytokines in Mycoplasma pneumonia infections [ J ]. Cytokine Growth Factor Rev, 2004, 15(2-3): 157-168.
  • 9Stelmach I, Podsiadlowicz-Borzecka M, Grzelewski T, Majak P, Stelmach W, Jerzynska J, et al. Humoral and cellular immunity in children with Mycoplasma pneumonia infection: a 1-year prospective study[J].Clin Diagn Lab Immunol, 2005, 12(10): 1246- 1250.
  • 10Kim CK, Chung CY, Kim JS, Kim WS, Park Y, Koh YY. Late abnormal findings on high resolution computed tomography after mycoplasma pneumonia [ J ]. Pediatrics, 2000, 105 ( 2 ) : 372- 378.

共引文献777

同被引文献13

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部